Traws Pharma, Inc. — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2021-02-16

Reporting Person: Shoemaker Mary Teresa (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-16	Common Stock	P	13000	$1.00	Acquired	50735	Direct

Footnotes

F1: Includes 37,735 shares held by the M. Teresa Shoemaker Revocable Trust U/A DTD 08/01/2000, of which the reporting person is a trustee.